POLYMED — Poly Medicure Balance Sheet
0.000.00%
- IN₹193.11bn
- IN₹182.75bn
- IN₹16.70bn
Annual balance sheet for Poly Medicure, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,743 | 3,517 | 3,013 | 2,923 | 12,102 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,011 | 2,590 | 2,878 | 3,225 | 4,166 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7,058 | 7,834 | 8,070 | 8,416 | 19,170 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3,910 | 4,770 | 6,624 | 8,889 | 11,302 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 12,237 | 13,768 | 15,772 | 18,587 | 31,925 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,714 | 2,267 | 2,933 | 3,512 | 3,702 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,582 | 2,894 | 3,356 | 3,886 | 4,268 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 9,656 | 10,875 | 12,416 | 14,701 | 27,657 |
| Total Liabilities & Shareholders' Equity | 12,237 | 13,768 | 15,772 | 18,587 | 31,925 |
| Total Common Shares Outstanding |